Gold | Independent Agency, 2021
The Bloc
Stay updated with breaking news from Abilify Maintena. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
®, the first FDA-approved digital medicine. Bill currently serves as Chairman of the Board of Directors of OPDC and is also the Chairman of the Board of the Sozosei Foundation, a newly established Otsuka charitable organization focused on decriminalization of mental illness. He serves on the boards of Excision BioTherapeutics, Saama and Annexon Biosciences and is Trustee of the non-profit Internet2. He is Board Chair Emeritus of the Sphinx Organization, which advocates for parity and inclusion in the arts. “Bill is an eminent figure in the biopharmaceutical community with a proven track re...
®, the first FDA-approved digital medicine. Bill currently serves as Chairman of the Board of Directors of OPDC and is also the Chairman of the Board of the Sozosei Foundation, a newly established Otsuka charitable organization focused on decriminalization of mental illness. He serves on the boards of Excision BioTherapeutics, Saama and Annexon Biosciences and is Trustee of the non-profit Internet2. He is Board Chair Emeritus of the Sphinx Organization, which advocates for parity and inclusion in the arts. “Bill is an eminent figure in the biopharmaceutical community with a proven track re...
Otsuka wants to create a next generation of kidney disease patients—Gen J. Short for Generation J, with the J standing for Jynarque, they're the first age group who may be able to control progression of their rare kidney disease with the Otsuka med.